LeonaBio Statistics
Total Valuation
LeonaBio has a market cap or net worth of $91.68 million. The enterprise value is $24.69 million.
| Market Cap | 91.68M |
| Enterprise Value | 24.69M |
Important Dates
The next estimated earnings date is Friday, July 31, 2026, after market close.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LeonaBio has 9.39 million shares outstanding. The number of shares has increased by 108.39% in one year.
| Current Share Class | 9.39M |
| Shares Outstanding | 9.39M |
| Shares Change (YoY) | +108.39% |
| Shares Change (QoQ) | +255.96% |
| Owned by Insiders (%) | 5.67% |
| Owned by Institutions (%) | 33.64% |
| Float | 5.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.86 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.38, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.38 |
| Quick Ratio | 10.15 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -298.76% and return on invested capital (ROIC) is -60.47%.
| Return on Equity (ROE) | -298.76% |
| Return on Assets (ROA) | -46.46% |
| Return on Invested Capital (ROIC) | -60.47% |
| Return on Capital Employed (ROCE) | -65.90% |
| Weighted Average Cost of Capital (WACC) | 15.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.81M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +124.47% in the last 52 weeks. The beta is 2.02, so LeonaBio's price volatility has been higher than the market average.
| Beta (5Y) | 2.02 |
| 52-Week Price Change | +124.47% |
| 50-Day Moving Average | 9.21 |
| 200-Day Moving Average | 6.79 |
| Relative Strength Index (RSI) | 60.26 |
| Average Volume (20 Days) | 37,757 |
Short Selling Information
The latest short interest is 51,630, so 0.55% of the outstanding shares have been sold short.
| Short Interest | 51,630 |
| Short Previous Month | 56,592 |
| Short % of Shares Out | 0.55% |
| Short % of Float | 0.92% |
| Short Ratio (days to cover) | 1.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -42.79M |
| Pretax Income | -129.41M |
| Net Income | -129.41M |
| EBITDA | -41.83M |
| EBIT | -42.79M |
| Earnings Per Share (EPS) | -$16.06 |
Balance Sheet
The company has $67.68 million in cash and $691,000 in debt, with a net cash position of $66.99 million or $7.13 per share.
| Cash & Cash Equivalents | 67.68M |
| Total Debt | 691,000 |
| Net Cash | 66.99M |
| Net Cash Per Share | $7.13 |
| Equity (Book Value) | 49.30M |
| Book Value Per Share | 5.25 |
| Working Capital | 62.54M |
Cash Flow
| Operating Cash Flow | -51.97M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 960,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -51.97M |
| FCF Per Share | -$5.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LeonaBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -108.39% |
| Shareholder Yield | -108.39% |
| Earnings Yield | -141.16% |
| FCF Yield | -56.68% |
Analyst Forecast
The average price target for LeonaBio is $18.00, which is 84.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.00 |
| Price Target Difference | 84.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Sep 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |